sudok1 / iStockphoto.com
17 October 2018Americas
FDA lifts hold on first human CRISPR trial
The US Food and Drug Administration (FDA) has allowed the first US-based human trial of CRISPR, the gene-editing technology, to proceed.
The US Food and Drug Administration (FDA) has allowed the first US-based human trial of CRISPR, the gene-editing technology, to proceed.
